GRDN Stock Guardian Pharmacy Services, Inc.
US · NYSEGuardian Pharmacy Services, Inc. is tracked by PrimeStockFinder but isn't in today's curated picks — the data below is real end-of-day market data. Picks refresh each weekday.
Is GRDN a buy right now?
Trend: GRDN is trading below the 50-day average (-3.45%), RSI 49 — neutral momentum, with a 3-month return of -4.87%.
Valuation & quality: Guardian Pharmacy Services, Inc. trades on a trailing P/E of 38.0, forward P/E 27.3, price-to-book 10.11; fundamentals show net margin 4.5%, return on equity 30.4%, revenue growth 2.2% year on year.
Analyst consensus: 7 analysts have a mean 12-month price target of $49.86 (+27.2% vs the last close; range $47.00 – $52.00), consensus rating “strong buy”.
Computed from end-of-day data; not personal advice.
Our track record with GRDN
Our simulated $10,000 funds have traded GRDN 1 time — 1 of 1 closed trade profitable.
| Fund | Bought | Sold | Return |
|---|---|---|---|
| US High-risk | 2026-09-07 @ $40.77 | 2026-09-15 @ $46.49 · AI review sell | +14.03% |
Paper trades from our simulated funds at real end-of-day prices; past results don't predict future returns.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +12.40% | -1.50% | +4.40% | +8.10% | -5.60% | -6.20% | +9.90% | -3.30% |
Fundamentals
Analyst price target
Technical signals
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States.
Sector: Healthcare · Industry: Medical Care Facilities · United States · 3,600 employees · Website
Related US picks
Browse: all US stocks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.